CRISPR Gene Editing Creates Hypoallergenic Beagles in First-of-Its-Kind Study
核心洞察
Scientists at Kindred Companion Sciences (搜索) used CRISPR (搜索) to knock out the main allergy-causing gene in dogs, producing two healthy hypoallergenic beagle pups named Bailey and Alfie born in September 2024.
Skin-prick allergy testing showed the researcher's skin reacted to poodle and goldendoodle extracts but not to samples from the gene-edited beagles, confirming reduced allergenicity.
The research, published in the CRISPR (搜索) Journal, represents the first successful application of this gene-editing approach in dogs, though long-term health monitoring and broader human testing are still needed.
Matt Walker, a geneticist who could never pet a dog without sneezing, can now play tug-of-war in his living room and share spoons of peanut butter with a beagle named Bailey — thanks to a pioneering application of CRISPR (搜索) gene editing that eliminated a key allergy-causing protein from the dog's saliva and hair.
Walker's company, Kindred Companion Sciences (搜索), created Bailey and her twin Alfie using the Nobel Prize-winning gene-editing technique, marking the first time such an approach has been successfully applied in dogs. The research was published Wednesday in the CRISPR (搜索) Journal.
"The feeling right now is sort of a mix of relief and awe and gratitude that it worked," said Walker.
How the Gene-Edited Beagles Were Created
To produce the hypoallergenic pups, scientists began in the laboratory by editing the genetic code inside dog skin cells, switching off the main gene responsible for producing allergy-causing proteins. The edited genetic code was then transferred into eggs that were implanted into a beagle surrogate, which gave birth to two healthy female pups in September 2024.
When researchers tested the saliva and fur of Alfie and Bailey, they found no signs of the targeted allergy-causing protein. They also conducted an allergy test by pricking Walker's skin with extracts from the beagles' saliva and dander. His skin reacted to samples from a poodle and goldendoodle — breeds often marketed as hypoallergenic — but showed no reaction to the gene-edited beagles.
A Different Approach from Past Attempts
Previous efforts to create hypoallergenic pets have relied primarily on cloning, but this approach led to sicker pups that were too genetically similar. Two years ago, researchers used CRISPR (搜索) to reduce levels of an allergy-causing protein in a cat named Alsik, though it remains unclear whether that technique is safe for broader feline testing.
Dogs that shed less, such as poodles, are frequently considered hypoallergenic by the public. However, these breeds still produce allergy-causing proteins in their saliva, hair, and dander, meaning they can still trigger symptoms in sensitive individuals.
Walker noted that all dogs possess the same allergy-causing gene that was edited in Alfie and Bailey. Kindred Companion Sciences (搜索) now hopes to test the technique on other dogs and service animals to determine whether an allergy-free line of pups can be bred beyond beagles.
Cautious Optimism and Unanswered Questions
Dr. Jeff SoRelle, a pathologist at University of Texas Southwestern Medical Center who was not involved in the study, emphasized the need for broader testing. "Future research should test the gene-edited hypoallergenic dogs on more people with pet allergies to be sure they can soothe symptoms across a broader swath of the human population," SoRelle said.
He also cautioned that since the switched-off gene is the main — but not the only — allergy-causing culprit in dogs, "we don't exactly know just how effective or broadly useful this could be for stopping dog allergy (搜索) in humans."
The genetic edit introduced in the beagles is rare but occurs naturally in some dogs, leading Walker to suggest it is unlikely to have negative health effects. Nonetheless, the pups will require monitoring through routine veterinary visits to ensure they remain healthy over the long term.
Ethical Considerations and Commercial Timeline
The development has drawn mixed reactions from experts. Bioethicist Arthur Caplan of New York University's Grossman School of Medicine acknowledged the potential benefits while raising concerns.
"It opens the door to a lot more people being able to own pets. On the negative side, it may discourage people from trying to use strays and unwanted animals that are not engineered to be allergy-free," Caplan said.
It will take years before the millions of people who suffer from dog-related allergies can purchase a gene-edited hypoallergenic dog. Scientists must first monitor the long-term health effects of the genetic modification and develop commercialization strategies to make the approach affordable.
Bailey now lives with Walker in New York, while Alfie resides in Florida with another Kindred scientist. For Walker, a lifelong dog lover whose allergies previously kept him from owning pets — even supposedly hypoallergenic breeds like his family's goldendoodle gave him itchy eyes and painful rashes — the breakthrough is deeply personal.
"It feels just amazing to get to have a dog," Walker said.